PharVision Advisers’s USA Today Co TDAY Stock Holding History

PharVision Advisers’s Portfolio TDAY Stock Details TDAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,436	Closed	-$51.4K	–	805
2025 Q3	$51.4K	Buy	+12,436	New	+$50K	0.03%	649

Other funds holding TDAY

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Philosophy Capital Management Alamo, California $1.63B AUM 12.69% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PharVision Advisers's TDAY Position: Q4 2025 in Review

PharVision Advisers sold out of USA Today Co (TDAY) in Q4 2025, closing a stake of 12,436 shares — an estimated $51.4K sold.

PharVision Advisers first reported a position in TDAY in Q3 2025 and held it in 1 quarter. The position peaked at $51.4K in Q3 2025. 192 funds tracked by Wall St. Rank hold TDAY as of Q4 2025.

PharVision Advisers reported no remaining USA Today Co position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 12,436 USA Today Co shares in Q4 2025, an estimated $51.4K.
PharVision Advisers first reported a position in USA Today Co in Q3 2025 and held it in 1 quarter.
PharVision Advisers's USA Today Co position peaked at $51.4K in Q3 2025.
192 funds tracked by Wall St. Rank held USA Today Co as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.